Extralehdet Extralehdet
The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.
Latest posts by Toimitus (see all)
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
Lisätietoja Toimitus
Katso myös
Who bombed the Iranian girls’ school, killing more than 170? What we know
The attack on Shajareh Tayyebeh Elementary School quickly became a focal point of concern over …